| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |